V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220004800 | 220001890 | 1.86 | 67.3 | Palliative (P) | 2013-04-19 | 2013-04-20 | Cytarabine Low Dose | N | N | 220026802 | CYTARABINE |
| 220004801 | 220001890 | 1.63 | null | Palliative (P) | 2013-11-29 | 2013-11-29 | Trial Unspecified | Y | N | 220026802 | TRIAL |
| 220004802 | 220001890 | null | 87.9 | Curative (C) | 2017-05-15 | 2017-05-15 | Trial Unspecified | 01 | N | 220026802 | TRIAL |
| 220004803 | 220001890 | null | 98 | Curative (C) | 2014-04-21 | 2014-04-21 | AML17 TRIAL | 2 | N | 220026802 | AML17 TRIAL |
| 220004804 | 220001890 | 1.63 | 87.5 | Palliative (P) | 2016-11-27 | 2016-11-27 | Trial Unspecified | Y | N | 220026802 | TRIAL |
| 220004805 | 220001891 | 1.76 | 66.1 | Palliative (P) | 2013-03-28 | 2013-04-03 | Trial Unspecified | Y | N | 220026816 | TRIAL |
| 220004806 | 220001891 | 1.92 | 76 | null | 2015-12-11 | 2015-12-14 | AML17 TRIAL | null | N | 220026816 | AML17 TRIAL |
| 220004807 | 220001891 | 1.65 | 102.5 | Curative (C) | 2014-05-21 | 2014-06-12 | Trial Unspecified | Y | N | 220026816 | TRIAL |
| 220004808 | 220001891 | null | 78.8 | Not known (9) | 2013-02-27 | 2013-03-05 | AML17 TRIAL | 02 | N | 220026816 | AML17 TRIAL |
| 220004810 | 220001893 | 1.83 | 78 | Palliative (P) | 2015-05-06 | 2015-05-06 | AML17 TRIAL | 1 | N | 220026833 | AML17 TRIAL |
| 220004811 | 220001893 | 1.87 | null | Curative (C) | 2012-12-20 | 2013-09-16 | AML17 TRIAL | N | N | 220026833 | AML17 TRIAL |
| 220004812 | 220001894 | null | 60.2 | Adjuvant (A) | 2017-08-29 | 2017-09-04 | AML17 TRIAL | N | N | 220026836 | AML17 TRIAL |
| 220004813 | 220001894 | 1.7 | 63 | null | 2017-01-18 | 2017-01-18 | AML17 TRIAL | N | N | 220026836 | AML17 TRIAL |
| 220004815 | 220001896 | 1.73 | 95.3 | Curative (C) | 2014-12-12 | 2014-12-12 | AML17 TRIAL | 01 | N | 220026839 | AML17 TRIAL |
| 220004816 | 220001896 | 1.67 | 88.4 | null | null | 2016-02-12 | AML17 TRIAL | 02 | null | 220026839 | AML17 TRIAL |
| 220004818 | 220010978 | 0 | 68 | null | 2015-12-02 | 2015-12-17 | Cytarabine Low Dose | N | N | 220026845 | CYTARABINE |
| 220004819 | 220001898 | null | null | Palliative (P) | null | 2015-10-26 | CYTARABINE | N | N | 220026846 | CYTARABINE |
| 220004820 | 220001899 | 1.68 | 78 | null | 2016-03-31 | 2016-03-31 | AML17 TRIAL | 02 | N | 220026853 | AML17 TRIAL |
| 220004821 | 220001900 | null | 96.6 | Curative (C) | 2015-08-09 | 2015-08-12 | AML17 TRIAL | N | N | 220026855 | AML17 TRIAL |
| 220004822 | 220001901 | null | 0 | Palliative (P) | 2015-02-12 | 2015-02-12 | CYTARABINE | Y | Y | 220026856 | CYTARABINE |
| 220004823 | 220010979 | 1.57 | 75 | Disease modification (D) | 2016-10-01 | 2016-10-01 | Cytarabine low (10to20mg/m2) IV/SC | null | null | 220026862 | CYTARABINE |
| 220004824 | 220010979 | 1.8 | 59.5 | Disease modification (D) | 2017-11-06 | 2017-11-12 | AML17 TRIAL | Y | N | 220026862 | AML17 TRIAL |
| 220004825 | 220001902 | 1.7 | null | Palliative (P) | 2015-07-20 | 2015-08-01 | Cytarabine Low Dose | 02 | N | 220026867 | CYTARABINE |
| 220004826 | 220001902 | 1.53 | 76 | Palliative (P) | 2014-02-26 | 2014-02-26 | CYTARABINE | N | N | 220026867 | CYTARABINE |
| 220004827 | 220015860 | 1.65 | null | Palliative (P) | 2017-12-14 | 2017-12-29 | CYTARABINE | N | N | 220026874 | CYTARABINE |
| 220004828 | 220015860 | 1.56 | 57.1 | Palliative (P) | 2013-12-13 | 2013-12-20 | Cytarabine Low Dose | N | N | 220026874 | CYTARABINE |
| 220004829 | 220015860 | 1.6 | null | null | 2016-04-26 | 2016-04-26 | Trial Unspecified | 1 | N | 220026874 | TRIAL |
| 220004830 | 220015860 | 1.64 | 102.3 | null | 2016-01-12 | 2016-01-15 | Cytarabine Low Dose | 02 | null | 220026874 | CYTARABINE |
| 220004831 | 220015860 | 1.41 | 66.4 | Not known (9) | 2013-11-03 | 2013-11-05 | Trial Unspecified | Y | null | 220026874 | TRIAL |
| 220004832 | 220001903 | 1.76 | null | Disease modification (D) | 2015-04-28 | 2015-05-03 | AML17 TRIAL | N | N | 220026889 | AML17 TRIAL |
| 220004833 | 220001904 | 1.86 | 60.9 | Curative (C) | 2017-05-31 | 2017-05-31 | Trial Unspecified | 01 | null | 220026890 | TRIAL |
| 220004834 | 220010981 | 1.6 | 70 | Palliative (P) | 2016-04-26 | 2016-04-26 | CYTARABINE | null | N | 220026891 | CYTARABINE |
| 220004837 | 220001906 | null | 95.6 | Curative (C) | 2013-06-26 | 2013-06-27 | LI-1 TRIAL | Y | null | 220026894 | TRIAL |
| 220004838 | 220001906 | null | 73.5 | Curative (C) | 2016-08-28 | 2016-08-28 | Trial Unspecified | 01 | N | 220026894 | TRIAL |
| 220004839 | 220015861 | 0 | 58.5 | Curative (C) | 2014-05-07 | 2014-07-05 | AML17 TRIAL | 2 | null | 220026897 | AML17 TRIAL |
| 220004840 | 220001907 | 1.75 | 88.6 | Curative (C) | 2017-02-23 | 2017-02-23 | Trial Unspecified | Y | N | 220026899 | TRIAL |
| 220004841 | 220001907 | null | 104 | null | 2014-03-24 | 2014-03-27 | Cytarabine Low Dose | 2 | N | 220026899 | CYTARABINE |
| 220004842 | 220001907 | 1.81 | 82.4 | Curative (C) | 2016-12-30 | 2017-01-02 | Trial Unspecified | 1 | N | 220026899 | TRIAL |
| 220004843 | 220001908 | 0 | null | null | 2015-09-14 | 2015-09-14 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220026910 | CYTARABINE |
| 220004844 | 220001908 | 1.67 | null | Palliative (P) | 2017-09-17 | 2017-09-22 | Cytarabine low (10to20mg/m2) IV/SC | 99 | N | 220026910 | CYTARABINE |
| 220004845 | 220015863 | 1.67 | 83.3 | Curative (C) | 2017-04-02 | 2017-04-12 | Trial Unspecified | Y | N | 220026919 | TRIAL |
| 220004846 | 220001909 | 1.76 | 75 | null | 2015-01-19 | 2015-01-19 | Trial Unspecified | 01 | N | 220026921 | TRIAL |
| 220004847 | 220001909 | 1.55 | 0 | Curative (C) | 2015-07-15 | 2015-07-16 | Trial Unspecified | 01 | N | 220026921 | TRIAL |
| 220004848 | 220001910 | 1.68 | 77 | Curative (C) | 2015-08-19 | 2015-08-24 | Trial Unspecified | Y | N | 220026923 | TRIAL |
| 220004849 | 220001910 | 1.78 | 81.2 | Adjuvant (A) | 2015-10-04 | 2015-10-09 | Cytarabine Low Dose | 99 | N | 220026923 | CYTARABINE |
| 220004850 | 220001910 | null | 75.6 | Curative (C) | 2016-03-10 | 2016-03-10 | Cytarabine Low Dose | N | N | 220026923 | CYTARABINE |
| 220004851 | 220018698 | 1.62 | 90 | Palliative (P) | 2016-07-04 | 2016-07-04 | Trial Unspecified | 1 | N | 220026928 | TRIAL |
| 220004852 | 220001911 | 1.81 | 55 | Curative (C) | 2017-11-06 | 2017-12-20 | AML17 TRIAL | N | N | 220026929 | AML17 TRIAL |
| 220004853 | 220001911 | null | null | Curative (C) | 2017-05-04 | 2017-05-04 | CYTARABINE | N | N | 220026929 | CYTARABINE |
| 220004854 | 220001911 | null | null | Palliative (P) | 2014-05-10 | 2014-05-10 | Cytarabine Low Dose | 02 | N | 220026929 | CYTARABINE |